Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial-Reference-Cited by-同舟云学术

Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial

Published:2019-07 Issue:10194 Volume:394 Page:230-239
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rissanen Tuomas T,Uskela Sanna,Eränen Jaakko,Mäntylä Pirjo,Olli Annika,Romppanen Hannu,Siljander Antti,Pietilä Mikko,Minkkinen Mikko J,Tervo Jerry,Kärkkäinen Jussi M,Vatanen Aija,Perälä Anssi,Müller Miriam,Porela Pekka,Palojoki Eeva

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Polymer-free drug-coated coronary stents in patients at high bleeding risk;Urban;N Engl J Med,2015

2. Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial;Varenne;Lancet,2018

3. Temporal trends in percutaneous coronary interventions thru the drug eluting stent era: insights from 18,641 procedures performed over 12-year period;Landes;Catheter Cardiovasc Interv,2018

4. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation;Cannon;N Engl J Med,2017

5. Prevention of bleeding in patients with atrial fibrillation undergoing PCI;Gibson;N Engl J Med,2016

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between the extent of dissection observed by intravascular ultrasound and long-term progression of vessel lesions after drug-coated balloon angioplasty in patients with de novo coronary artery disease;2024-09-08

2. Intravascular lithotripsy in coronary arteries: a review of case reports;The Egyptian Heart Journal;2024-09-07

3. Unravelling the progress and potential of drug-eluting stents and drug-coated balloons in cardiological insurgencies;Life Sciences;2024-09

4. How feasible is a cage-free solution for de novo coronary artery disease?;The Lancet;2024-09

5. One-Month Duration Compared with Twelve-Month Duration of Dual Antiplatelet Therapy in Elective Angioplasty for Coronary Artery Disease: Bleeding and Ischaemic Outcomes;Journal of Clinical Medicine;2024-08-02